In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Toshiba American Medical Systems

This article was originally published in The Gray Sheet

Executive Summary

Formation of a new management team for the company's Ultrasound Business Unit has been completed, Toshiba states. Members of the management team include: T. Michael McLean, vice president, Ultrasound Business Unit, who was most recently vice president for Johnson & Johnson Clinical Diagnostics; Eli Wisner, director, Ultrasound Sales, who was previously general manager for Percusurge; and Ross Heaton, director, Ultrasound Marketing, who was senior vice president of marketing and sales for Perception Ultrasound International. The company says formation of this team "comes at a particularly important time as Toshiba launches its PowerVision 6000 system." Toshiba launched the PowerVision 6000 May 19 at the Leading Edge conference in Atlantic City, New Jersey. The mobile, 256-channel digital system offers high-end capabilities at a mid-range price, the firm claims...

You may also be interested in...

Dosing Guidance Lacking For Leading COVID-19 Antiviral Therapies, ASHP Analysis Shows

Health-system pharmacist organization assesses the evidence behind off-label use of existing drugs for COVID-19, along with top investigational prospects like Gilead’s remdesivir. 

Quality Should Ride Shotgun As US Auto Makers Rev Engine On Making Ventilators

As American auto giants GM and Ford take the wheel on working with ventilator manufacturers to make the critically needed devices during the COVID-19 pandemic, two longtime quality experts explain where the device and auto companies will find common ground when it comes to quality systems.

PBMI: Managing Specialty Drug Costs, Working With ICER And Promoting Transparency

Despite a reprieve last summer from the Trump administration’s proposed drug price rebate rule, speakers at the 25th annual Pharmacy Benefit Manager Institute kept the focus on price transparency and talked up new ways to manage drug costs for patients in need of treatment. 




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts